US Patent 8394790 Psychotropic agents having glutamate NMDA activity
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
The invention provides novel compounds and pharmaceutical compositions for the treatment of psychological and/or psychiatric diseases or disorders.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Avraham Weizman0
Irit Gil-Ad0
Moshe Portnoy0
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08394790 Psychotropic agents having glutamate NMDA activity US Patent 8394790 Psychotropic agents having glutamate NMDA activity
Infobox
Patent Number
083947900
Patent Number
83947900
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
083947900
Date of Patent
March 12, 2013
0Patent Application Number
124473810
Date Filed
October 25, 2007
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08394790 Psychotropic agents having glutamate NMDA activity
Infobox
Is a
Patent jurisdiction
Patent number
08394790
Date of patent
March 12, 2013
Patent application number
12447381
Date Filed
October 25, 2007
Patent primary examiner
Find more entities like US Patent 8394790 Psychotropic agents having glutamate NMDA activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.